Analytical Data
-
基因名
SLC41A2
- Application
-
别名
SLC41A2; Solute carrier family 41 member 2
-
种属
Human
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96JW4
-
表达区间
1-162aa
-
分子量
22 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC41A2, a member of the SLC (solute carrier) family, is a putative magnesium transporter that has garnered attention due to its potential role in cellular magnesium homeostasis, which is vital for numerous physiological processes. Recent studies have indicated that SLC41A2 may be involved in various biological functions, including cellular signaling, energy metabolism, and protein synthesis, making it a candidate for further investigation in the context of diseases related to magnesium deficiency. The interest in recombinant SLC41A2 protein arises from the need to elucidate its functional mechanisms, structural properties, and interactions within the cell. By expressing SLC41A2 as a recombinant protein, researchers aim to investigate its transport activity, identify its substrate specificity, and determine the effects of mutations observed in genetic studies. Understanding the role of SLC41A2 in magnesium transport could provide insights into pathologies such as cardiovascular diseases, neurological disorders, and metabolic syndromes, where magnesium plays a critical role. Furthermore, elucidating the molecular mechanisms by which SLC41A2 operates may offer novel therapeutic targets for interventions in magnesium-related disorders, thus highlighting the significance of this protein within the broader scope of health and disease management.












